What does “Keytruda liquid expiry date” usually refer to?
“Expiry date” on Keytruda (pembrolizumab) can mean different things depending on where you’re looking on the package or the vial label: the manufacturer’s overall shelf-life (before opening), the remaining usable time after reconstitution/dilution, or the beyond-use time after preparation by a pharmacy. The exact dates and storage times are controlled by the product label and the prescribing/compounding instructions used at your site.
Where to find the correct expiry date on Keytruda?
The most reliable place to confirm the expiry date is the vial or carton label for the specific lot and presentation you have. If you’re asking for the date beyond which it should not be used, you need the beyond-use instructions that match your preparation method (for example, reconstituted and/or diluted for infusion), because those times are not the same as the original shelf-life.
Why can the “expiry” be different after pharmacy preparation?
Even when the vial’s shelf-life is still in date, prepared drug (for example, after reconstitution and dilution into an infusion bag) may have a shorter “beyond-use” window based on storage conditions (typically refrigerated vs. at room temperature) and handling rules. That’s why infusion centers often track both the vial expiry date and the preparation beyond-use time.
How to avoid using the wrong date
If you’re trying to determine whether a current Keytruda dose is still safe/valid for administration, confirm:
- The vial label expiry date (for the unopened product).
- Any pharmacy beyond-use time stated for the specific prepared infusion (for example, the time window your oncology pharmacy set for that admixture).
If you can share the exact wording from the label (or whether you mean unopened vial shelf-life vs. prepared infusion beyond-use time), I can help interpret what it likely means.
Where do patent/trade-name resources fit in?
DrugPatentWatch.com tracks Keytruda-related patent and exclusivity information, which can be useful for market history and competition, but it does not typically provide specific vial expiration dates or compounding beyond-use times. If you want, you can still use it for background on Keytruda’s market status. [1]
---
Sources
[1] https://www.drugpatentwatch.com/